Get started
Author

Urvi Shah

Observed names: Shah, Urvi A., Shah, Urvi Ajay, Urvi A. Shah, Urvi Ajay Shah
ORCID: 0000-0001-8419-1091
Observed ORCID: 0000-0001-8419-1091
OpenAlex ID: A5006000406
Tumor Markers in Pancreatic Cancer: 2013
2013 · Shah, Urvi Ajay, Saif, Muhammad Wasif · PubMed · 10
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM
2026 · Kylee H. Maclachlan, Carlyn R. Tan, et al. · Blood Advances · 7
PDF
Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis
2014 · Ojas H. Vyas, Esha Kaul, et al. · Blood · 6
Long-term progression-free survival benefit with ciltacabtagene autoleucel in standard-risk relapsed / refractory multiple myeloma
2025 · Luciano Costa, Albert Oriol, et al. · Blood · 5
Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies
2026 · Issam S. Hamadeh, Maximillian Merz, et al. · Clinical Lymphoma Myeloma & Leukemia · 3
Oncologists Knowledge and Attitudes Towards Providing Dietary Guidance to Patients With Cancer
2026 · Shireen Kassam, Zahra Kassam, et al. · American Journal of Lifestyle Medicine · 1
A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma
2026 · Urvi A. Shah, Andriy Derkach, et al. · Haematologica
Dietary Fiber Intake Correlates With Improved Allo-HCT Survival and Supports Development of a High-Fiber Trial
2026 · Jenny Paredes, Tyler Funnell, et al. · Current Developments in Nutrition
Dietary fiber intake associates with improved survival and microbiome composition in allogeneic hematopoietic cell transplantation
2026 · Jenny Paredes, Tyler Funnell, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Figure S6. from A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
2026 · Urvi A. Shah, Laura Lucia Cogrossi, et al.
Dietary patterns among individuals with plasma cell disorders– opportunities for targeted interventions
2026 · Kadiatou Traore, Francesca Castro, et al. · Blood Cancer Journal
PDF
Diagnosis Disclosure and Related Illness Experience in Patients With Multiple Myeloma and Precursor Plasma Cell Disorders
2026 · Maria A. Malik, Akshay A. Dalvi, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
CD8+CD38+ T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates
2026 · Nezar Mehanna, Andriy Derkach, et al. · Blood Neoplasia
Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial
2026 · Roberto Mina, Anne K. Mylin, et al. · Journal of Patient-Reported Outcomes
Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial
2026 · Mina, Roberto, Mylin, Anne K., et al. · Figshare
Additional file 1 of Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial
2026 · Mina, Roberto, Mylin, Anne K., et al. · Figshare
International Conference on Nutrition in Medicine Proceedings 2025
2026 · Kim Allan Williams, Gemma Newman, et al. · International Journal of Disease Reversal and Prevention
Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single‐cell profiling in anti‐BCMA CAR T‐treated myeloma
2026 · Thomas C. Wiemers, Michael Rade, et al. · HemaSphere
Maintenance Therapy with Iberdomide Following Autologous Hematopoietic Cell Transplantation in Lenalidomide-Exposed Multiple Myeloma Patients
2026 · Natalia Tijaro Ovalle, Malin Hultcrantz, et al. · Transplantation and Cellular Therapy
Precision Melphalan Dosing Using a Population Pharmacokinetic Model Combined with IL-6 Blockade (Siltuximab) in Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplantation: Phase II Lead-in Outcomes
2026 · Natalia Tijaro Ovalle, Andrew Lin, et al. · Transplantation and Cellular Therapy
Lenalidomide-related diarrhea is associated with gut microbiota dysbiosis and disruption of the bile acid pool
2025 · Kevin Miller, Teng Fei, et al. · Blood
PDF
Abstract 20477: Impact of Same-Hospital Readmissions in Heart Failure Patient Population
2017 · Shilpkumar Arora, Varun Kumar, et al. · Circulation
Improvement of Blood Glucose Control on the Bone Marrow Transplant (BMT) Unit: A Retrospective Review of Our Quality Improvement Pilot Program
2014 · Gunjan L. Shah, Aaron Rosenberg, et al. · Transplantation and Cellular Therapy
PDF
Works count: 23
Citation count: 32
H-index: 4
I10-index: 1
Year
Topic
Type